Genovate Biotechnology Co (ROCO:4130) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4130 Genovate Biotechnology Co Ltd ROCO:4130
67 GF Score
Price NT$26.70
GF Value NT$19.99
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Genovate Biotechnology Co Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

ROCO:4130
67GF Score
Genovate Biotechnology Co Ltd ROCO:4130
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Genovate Biotechnology Co (ROCO:4130) Overvalued in 2026?

Based on GuruFocus' analysis, Genovate Biotechnology Co stock appears to be overvalued. The current stock price of NT$26.70 is trading 33.6% above its estimated GF Value™ of NT$19.99. GuruFocus considers Genovate Biotechnology Co to be Significantly Overvalued.

Key valuation signals for ROCO:4130:

  • Dividends Received:
  • GF Value™: NT$19.99 vs. price of NT$26.70 (33.6% above fair value)
  • GF Score™: 67/100 with 1 warning sign

No single metric tells the full story. See the ROCO:4130 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Genovate Biotechnology Co Business Description

Address No.1, First Industrial Road, Hsin-Chu Expanded Park, Hukou Township, Guangdong Province, Hsin-Chu county, Hsin-Chu, TWN, 303036
Genovate Biotechnology Co Ltd develops, produces, manufactures, and sales of medicines for the prevention and treatment of diseases caused by viruses and bacteria, and medicines for the treatment of cardiovascular, gastrointestinal, cancer, and autoimmune diseases, etc. The company is also engaged in the sales of medicines for the prevention and treatment of diseases caused by viruses and bacteria, and medicines for the treatment of cardiovascular, gastrointestinal, cancer, and autoimmune diseases etc.
67GF Score

Get the complete analysis for ROCO:4130

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$26.70
Price
NT$19.99
GF Value